{"id":"https://openalex.org/W188701504","doi":null,"title":"Rational therapeutic options for patients with myeloproliferative neoplasms.","display_name":"Rational therapeutic options for patients with myeloproliferative neoplasms.","publication_year":2011,"publication_date":"2011-01-01","ids":{"openalex":"https://openalex.org/W188701504","mag":"188701504","pmid":"https://pubmed.ncbi.nlm.nih.gov/21686205","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3116330"},"language":"en","primary_location":{"id":"pmid:21686205","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21686205","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Transactions of the American Clinical and Climatological Association","raw_type":"Journal Article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3116330/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006372952","display_name":"Ronald Hoffman","orcid":"https://orcid.org/0000-0001-6564-6732","observed_orcids":["https://orcid.org/0000-0001-6564-6732"]},"institutions":[{"id":"https://openalex.org/I4390039328","display_name":"Tisch Cancer Institute","ror":"https://ror.org/0317dzj93","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1320796813","https://openalex.org/I4390039328","https://openalex.org/I98704320"]},{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ronald Hoffman","raw_affiliation_strings":["Myeloproliferative Disorders Program, Tisch Cancer Institute, Department of Medicine, Mount Sinai School of Medicine, Box 1079, One Gustave L. Levy Place, New York, NY 10029, USA. ronald.hoffman@mssm.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Myeloproliferative Disorders Program, Tisch Cancer Institute, Department of Medicine, Mount Sinai School of Medicine, Box 1079, One Gustave L. Levy Place, New York, NY 10029, USA. ronald.hoffman@mssm.edu","institution_ids":["https://openalex.org/I4390039328","https://openalex.org/I98704320"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5006372952"],"corresponding_institution_ids":["https://openalex.org/I4390039328","https://openalex.org/I98704320"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"122","issue":null,"first_page":"11","last_page":"26"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13374","display_name":"Hematological disorders and diagnostics","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/primary-myelofibrosis","display_name":"primary myelofibrosis","score":0.9819999933242798},{"id":"https://openalex.org/keywords/myeloproliferative-neoplasms","display_name":"myeloproliferative neoplasms","score":0.9769999980926514},{"id":"https://openalex.org/keywords/jak2-inhibitors","display_name":"JAK2 inhibitors","score":0.9879999756813049},{"id":"https://openalex.org/keywords/jak2-v617f-mutation","display_name":"JAK2 V617F mutation","score":0.8799999952316284},{"id":"https://openalex.org/keywords/allogeneic-stem-cell-transplantation","display_name":"allogeneic stem cell transplantation","score":0.9160000085830688},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia-transformation","display_name":"acute myeloid leukemia transformation","score":0.8259999752044678},{"id":"https://openalex.org/keywords/hematopoietic-microenvironment","display_name":"hematopoietic microenvironment","score":0.9399999976158142},{"id":"https://openalex.org/keywords/splenomegaly","display_name":"splenomegaly","score":0.9129999876022339},{"id":"https://openalex.org/keywords/transfusion-requirements","display_name":"transfusion requirements","score":0.7480000257492065},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.3370000123977661},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5009999871253967}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7496945261955261},{"id":"https://openalex.org/C2780076729","wikidata":"https://www.wikidata.org/wiki/Q1752571","display_name":"Myelofibrosis","level":3,"score":0.684162437915802},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.5087667107582092},{"id":"https://openalex.org/C109159458","wikidata":"https://www.wikidata.org/wiki/Q919283","display_name":"Haematopoiesis","level":3,"score":0.4648061990737915},{"id":"https://openalex.org/C2776112149","wikidata":"https://www.wikidata.org/wiki/Q7383611","display_name":"Ruxolitinib","level":4,"score":0.4569145143032074},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.44935935735702515},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.4409981667995453},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.4273691773414612},{"id":"https://openalex.org/C2777408962","wikidata":"https://www.wikidata.org/wiki/Q1128050","display_name":"Hematopoietic stem cell transplantation","level":3,"score":0.41764071583747864},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.4136629104614258},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.37688109278678894},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.36221519112586975},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.34145665168762207},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32283616065979004},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.20637106895446777},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.12317556142807007},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006410","descriptor_name":"Hematopoiesis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006412","descriptor_name":"Hematopoietic Stem Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D006412","descriptor_name":"Hematopoietic Stem Cells","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D006412","descriptor_name":"Hematopoietic Stem Cells","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010677","descriptor_name":"Philadelphia Chromosome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D033581","descriptor_name":"Stem Cell Transplantation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D053614","descriptor_name":"Janus Kinase 2","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D053614","descriptor_name":"Janus Kinase 2","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D053614","descriptor_name":"Janus Kinase 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D055153","descriptor_name":"Stem Cell Niche","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D055153","descriptor_name":"Stem Cell Niche","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D055728","descriptor_name":"Primary Myelofibrosis","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D055728","descriptor_name":"Primary Myelofibrosis","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D055728","descriptor_name":"Primary Myelofibrosis","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D055728","descriptor_name":"Primary Myelofibrosis","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"pmid:21686205","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21686205","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Transactions of the American Clinical and Climatological Association","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3116330","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3116330/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Trans Am Clin Climatol Assoc","raw_type":"Text"},{"id":"mag:188701504","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21686205","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:3116330","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3116330/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Trans Am Clin Climatol Assoc","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G9000865260","display_name":"Myeloproliferative Neoplasms-Research Consortium","funder_award_id":"P01CA108671","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":59,"referenced_works":["https://openalex.org/W246907960","https://openalex.org/W1421162947","https://openalex.org/W1535534106","https://openalex.org/W1540109687","https://openalex.org/W1966318910","https://openalex.org/W1979421565","https://openalex.org/W1983343123","https://openalex.org/W1986595955","https://openalex.org/W1987930421","https://openalex.org/W1988879621","https://openalex.org/W1989702202","https://openalex.org/W1998593414","https://openalex.org/W2000642246","https://openalex.org/W2016086822","https://openalex.org/W2020622102","https://openalex.org/W2025548855","https://openalex.org/W2028803880","https://openalex.org/W2029449323","https://openalex.org/W2029712941","https://openalex.org/W2030570405","https://openalex.org/W2030739472","https://openalex.org/W2045830618","https://openalex.org/W2048866300","https://openalex.org/W2049145190","https://openalex.org/W2053957621","https://openalex.org/W2057496731","https://openalex.org/W2060833726","https://openalex.org/W2063355387","https://openalex.org/W2064812526","https://openalex.org/W2066616821","https://openalex.org/W2076709820","https://openalex.org/W2078844752","https://openalex.org/W2079836359","https://openalex.org/W2085603059","https://openalex.org/W2089483984","https://openalex.org/W2094456737","https://openalex.org/W2096638244","https://openalex.org/W2096760836","https://openalex.org/W2106609638","https://openalex.org/W2107268345","https://openalex.org/W2107398329","https://openalex.org/W2110190127","https://openalex.org/W2112331465","https://openalex.org/W2116529351","https://openalex.org/W2117431306","https://openalex.org/W2123633897","https://openalex.org/W2129219546","https://openalex.org/W2136280424","https://openalex.org/W2137437637","https://openalex.org/W2146505525","https://openalex.org/W2154992334","https://openalex.org/W2160450666","https://openalex.org/W2161214210","https://openalex.org/W2161735519","https://openalex.org/W2229128134","https://openalex.org/W2275311108","https://openalex.org/W2337803710","https://openalex.org/W2409915490","https://openalex.org/W2411769793"],"related_works":["https://openalex.org/W4387047327","https://openalex.org/W1979461781","https://openalex.org/W2334548251","https://openalex.org/W2533455343","https://openalex.org/W2552762343","https://openalex.org/W2170830128","https://openalex.org/W2008105940","https://openalex.org/W2802827677","https://openalex.org/W4224311929","https://openalex.org/W2138157242"],"abstract_inverted_index":{"Patients":[0],"with":[1,78,100,220,233],"advanced":[2],"forms":[3],"of":[4,12,21,35,38,42,53,70,85,107,120,128,133,176,193,207,244],"primary":[5],"myelofibrosis":[6],"(PMF)":[7],"have":[8,154,180],"an":[9,200],"average":[10],"survival":[11],"4":[13],"to":[14,76,136,173,183,230],"5":[15],"years.":[16],"At":[17],"present,":[18],"the":[19,33,51,60,68,83,97,113,118,125,131,194,209,221,227,242],"standard":[20],"care":[22],"for":[23,65,188],"these":[24,92],"patients":[25,77,232],"is":[26],"largely":[27],"palliative,":[28],"including":[29,226],"supportive":[30],"measures":[31],"and":[32,87,130],"use":[34],"a":[36,164,238],"variety":[37],"therapeutic":[39,186,202,224],"agents,":[40],"each":[41],"which's":[43],"directed":[44,162],"toward":[45],"reducing":[46],"transfusion":[47],"requirements":[48],"or":[49,110,149],"decreasing":[50],"degree":[52,84],"splenomegaly.":[54],"Currently,":[55],"allogeneic":[56],"stem-cell":[57],"transplantation":[58],"remains":[59],"only":[61],"potentially":[62],"curative":[63,175],"approach":[64],"PMF.":[66,177],"Although":[67],"administration":[69],"Janus":[71],"Kinase":[72],"2":[73],"(JAK2)":[74],"inhibitors":[75],"PMF":[79,129,153,198,213],"often":[80],"dramatically":[81],"reduces":[82],"splenomegaly":[86],"improves":[88],"in":[89,152,197,212,218,241],"systemic":[90],"symptoms,":[91],"drugs":[93],"do":[94,103],"not":[95],"correct":[96],"cytopenias":[98],"associated":[99],"PMF,":[101,234],"nor":[102],"they":[104],"reverse":[105],"abnormalities":[106,210],"BM":[108],"architecture":[109],"substantially":[111],"influence":[112],"JAK2V617F":[114,151,170],"allele":[115],"burden.":[116],"Furthermore,":[117],"effects":[119],"such":[121,168,245],"small-molecule":[122],"therapy":[123],"on":[124],"natural":[126],"history":[127],"rate":[132],"its":[134],"evolution":[135],"acute":[137],"myeloid":[138],"leukemia":[139],"(AML)":[140],"remain":[141],"uncertain.":[142],"Recently,":[143],"additional":[144],"genetic":[145,166],"alterations":[146],"that":[147,160],"precede":[148],"accompany":[150],"been":[155],"documented.":[156],"These":[157,178],"findings":[158],"indicate":[159],"therapies":[161],"against":[163],"single":[165],"lesion":[167],"as":[169],"are":[171],"unlikely":[172],"be":[174,216],"observations":[179],"led":[181],"us":[182],"consider":[184],"alternative":[185],"targets":[187],"drug":[189],"development.":[190],"The":[191],"dysregulation":[192],"hematopoietic":[195],"microenvironment":[196],"provides":[199],"attractive":[201],"target.":[203],"Novel":[204],"agents":[205],"capable":[206],"correcting":[208],"seen":[211],"would":[214,236],"probably":[215],"used":[217],"combination":[219],"currently":[222],"available":[223],"armamentarium,":[225],"JAK2":[228],"inhibitors,":[229],"treat":[231],"which":[235],"represent":[237],"paradigm":[239],"shift":[240],"management":[243],"patients.":[246]},"counts_by_year":[],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}